首页> 外文期刊>Journal of the Medical Association of Thailand =: Chotmaihet thangphaet >Combined maternal serum inhibin A and embryonic/ fetal heart rate for the prediction of pregnancy outcome in a first-trimester threatened abortion.
【24h】

Combined maternal serum inhibin A and embryonic/ fetal heart rate for the prediction of pregnancy outcome in a first-trimester threatened abortion.

机译:结合母体血清抑制素A和胚胎/胎儿心率来预测早孕先兆流产的妊娠结局。

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVE: To examine the value of combined maternal serum inhibin A and embryonic/fetal heart rate to predict the pregnancy outcome in a first-trimester threatened abortion. MATERIALS AND METHOD: This was a prospective observational study. The authors measured maternal serum inhibin A and the embryonic/fetal heart rate in women with a clinical diagnosis of a threatened abortion and in normal pregnant women. The main outcome measured was ongoing normal pregnancies. RESULTS: Thirty women with threatened abortions and 30 normal pregnant women were followed. Three women with threatened abortions ended in failed pregnancies. The mean embryonic/fetal heart rate and the median of serum inhibin A in the threatened abortion group were not different from the control group. In women with threatened abortions and failing pregnancies, the embryonic/fetal heart rate (101.7 +/- 20.1 beats/min) was significantly lower than in women with threatened abortions but ongoing pregnancies (163.3 +/- 19.7 beats/min, p = 0.024). Serum inhibin A in women with threatened abortions and failing pregnancies was not different from women with threatened abortions but ongoing pregnancies (median) 274.0 vs. 559.9 pg/mL, p = 0.388). When using serum inhibin A combined with embryonic/fetal heart rate, or only embryonic/fetal heart rate, the sensitivity and specificity for predicting an ongoing pregnancy were 100% and 50% or 100% and 100%, respectively. CONCLUSION: Combined maternal serum inhibin A and embryonic/fetal heart rate is not better than embryonic/fetal heart rate for predicting the pregnancy outcome in a first-trimester threatened abortion.
机译:目的:研究母体血清抑制素A和胚胎/胎儿心率相结合的价值,以预测早孕先兆流产的妊娠结局。材料与方法:这是一项前瞻性观察研究。作者测量了临床诊断为先兆流产的妇女和正常孕妇的母亲血清抑制素A和胚胎/胎儿心率。所测得的主要结局是正在进行的正常妊娠。结果:30名先兆流产妇女和30名正常孕妇被随访。三名流产受威胁的妇女以怀孕失败告终。先兆流产组的平均胚胎/胎儿心率和血清抑制素A的中位数与对照组无差异。在先兆流产和妊娠失败的妇女中,胚胎/胎儿心率(101.7 +/- 20.1次/分)明显低于先兆流产但正在妊娠的妇女(163.3 +/- 19.7次/分,p = 0.024 )。高危流产和妊娠失败妇女的血清抑制素A与高危流产妇女没有区别,但持续妊娠(中位)为274.0 vs. 559.9 pg / mL,p = 0.388)。当使用血清抑制素A结合胚胎/胎儿心率或仅胚胎/胎儿心率时,预测持续妊娠的敏感性和特异性分别为100%和50%或100%和100%。结论:母体血清抑制素A和胚胎/胎儿心率的结合不能优于胚胎/胎儿心率,以预测早孕先兆流产的妊娠结局。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号